Kirill Dmitriev, director of the Russian Direct Investment Fund (RDIF), expects Russia to register the Sputnik V vaccine in Brazil in December. The Gamaleya Institute is developing the vaccine, which is in phase 3 of clinical trials.
The Russian vaccine will be produced in the country in partnership with the pharmaceutical company União Química. The Bahia government already purchased 50 million doses to be delivered directly from the Russian institute.
The government of Paraná also signed an agreement for the production of the vaccine, which includes technology transfer. There is still no information on whether the federal government will sign an agreement with Russia to make the vaccine available in SUS.
The information was announced during a press interview on Monday (19). In addition to Brazil, Russia plans to enter into agreements with other countries in Latin America to produce Sputnik V doses, including Argentina, Uruguay, Peru, and Mexico.
Translated by Kiratiana Freelon